Evidence-Based Medicine Guidelines
Ribavirin monotherapy for chronic hepatitis C
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Ribavirin Monotherapy for Chronic Hepatitis C." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/455073/all/Ribavirin_monotherapy_for_chronic_hepatitis_C.
Ribavirin monotherapy for chronic hepatitis C. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. https://evidence.unboundmedicine.com/evidence/view/EBMG/455073/all/Ribavirin_monotherapy_for_chronic_hepatitis_C. Accessed December 22, 2024.
Ribavirin monotherapy for chronic hepatitis C. (2024). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/455073/all/Ribavirin_monotherapy_for_chronic_hepatitis_C
Ribavirin Monotherapy for Chronic Hepatitis C [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. [cited 2024 December 22]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/455073/all/Ribavirin_monotherapy_for_chronic_hepatitis_C.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Ribavirin monotherapy for chronic hepatitis C
ID - 455073
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/455073/all/Ribavirin_monotherapy_for_chronic_hepatitis_C
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
